Reds-III
Ended Awarded Last action
- Contract number
- HHSN26800002
- Awardee
-
Vitalant UEI GKT4L2JZJ622
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $8,847,513
Award facts
- Contract value 100% obligated
- $8,847,513.18 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost No Fee
- Place of performance
- San Francisco, CA 94118, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | $0 | |
| Other Administrative Action | -$3,740 | |
| Change Order | -$463,488 | |
| Other Administrative Action | -$156,259 | |
| Other Administrative Action | -$88,813 | |
| Change Order | $0 | |
| Other Administrative Action | -$2,166 | |
| Other Administrative Action | $0 | |
| Change Order | $249,959 | |
| Funding Only Action | $234,609 | |
| Funding Only Action | $200,000 | |
| Funding Only Action | $820,020 | |
| Funding Only Action | $158,260 | |
| Change Order | $234,844 | |
| Change Order | $130,886 | |
| Supplemental Agreement for work within scope | $3,403,680 | |
| Supplemental Agreement for work within scope | $89,857 | |
| Change Order | -$3,750,930 | |
| Original award | $7,790,794 |
Show all 19
About this award
This federal contract was awarded by the National Heart Lung and Blood Institute (NHLBI), part of the National Institutes of Health (NIH), to Vitalant, a nonprofit organization that provides blood products and conducts research related to transfusion medicine. The contract, titled "REDS-III" (Recipient Epidemiology and Donor Evaluation Study - III), has a ceiling value of $8,847,513.18 and a period of performance ending on December 31, 2019. The contract does not have a set-aside designation.
As the prime contractor, Vitalant's Vitalant Research Institute (VRI) division is responsible for providing a range of services, including supplying blood products, conducting research and analysis, and establishing a repository of blood samples to support the broader REDS-III program. VRI has subcontracted with the University of California, San Francisco and the University of Pittsburgh to assist with study design, protocol development, genetic and metabolomic analysis, and sample management. The REDS-III program focuses on identifying genetic and metabolic factors that influence red blood cell storage and hemolysis, with the goal of improving the safety and efficacy of blood transfusions.
Quick answers
Who was awarded contract HHSN26800002?
HHSN26800002 was awarded to Vitalant by National Heart Lung and Blood Institute (National Institutes of Health) on March 13, 2013.
How much is contract HHSN26800002 worth?
The government has obligated $8,847,513 on HHSN26800002.
Is contract HHSN26800002 an order under another contract?
Yes. HHSN26800002 is a delivery order under HHSN268201100001I, an indefinite delivery contract.
Was contract HHSN26800002 competed?
The extent of competition for HHSN26800002 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award